Health In Menopause Limited 12167424 false 2023-09-01 2024-08-31 2024-08-31 The principal activity of the company is Menopause Health Digita Accounts Production Advanced 6.30.9574.0 true 12167424 2023-09-01 2024-08-31 12167424 2024-08-31 12167424 core:RetainedEarningsAccumulatedLosses 2024-08-31 12167424 core:ShareCapital 2024-08-31 12167424 core:CurrentFinancialInstruments 2024-08-31 12167424 core:CurrentFinancialInstruments core:WithinOneYear 2024-08-31 12167424 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-08-31 12167424 core:FurnitureFittingsToolsEquipment 2024-08-31 12167424 core:LandBuildings 2024-08-31 12167424 bus:SmallEntities 2023-09-01 2024-08-31 12167424 bus:AuditExemptWithAccountantsReport 2023-09-01 2024-08-31 12167424 bus:FilletedAccounts 2023-09-01 2024-08-31 12167424 bus:SmallCompaniesRegimeForAccounts 2023-09-01 2024-08-31 12167424 bus:RegisteredOffice 2023-09-01 2024-08-31 12167424 bus:Director1 2023-09-01 2024-08-31 12167424 bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 12167424 bus:Agent1 2023-09-01 2024-08-31 12167424 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-09-01 2024-08-31 12167424 core:IntangibleAssetsOtherThanGoodwill 2023-09-01 2024-08-31 12167424 core:FurnitureFittingsToolsEquipment 2023-09-01 2024-08-31 12167424 core:LandBuildings 2023-09-01 2024-08-31 12167424 core:LeaseholdImprovements 2023-09-01 2024-08-31 12167424 core:OfficeEquipment 2023-09-01 2024-08-31 12167424 countries:EnglandWales 2023-09-01 2024-08-31 12167424 2023-08-31 12167424 core:FurnitureFittingsToolsEquipment 2023-08-31 12167424 core:LandBuildings 2023-08-31 12167424 2022-09-01 2023-08-31 12167424 2023-08-31 12167424 core:RetainedEarningsAccumulatedLosses 2023-08-31 12167424 core:ShareCapital 2023-08-31 12167424 core:CurrentFinancialInstruments 2023-08-31 12167424 core:CurrentFinancialInstruments core:WithinOneYear 2023-08-31 12167424 core:FurnitureFittingsToolsEquipment 2023-08-31 12167424 core:LandBuildings 2023-08-31 iso4217:GBP xbrli:pure

Registration number: 12167424

Health In Menopause Limited

Unaudited Abridged Financial Statements

(Companies House version)

for the Year Ended 31 August 2024

 

Health In Menopause Limited

Contents

Accountants' Report

1

Abridged Balance Sheet

2 to 3

Notes to the Unaudited Abridged Financial Statements

4 to 7

 

Chartered Accountants' Report to the Director on the Preparation of the Unaudited Statutory Accounts of
Health In Menopause Limited
for the Year Ended 31 August 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Health In Menopause Limited for the year ended 31 August 2024 as set out on pages 2 to 7 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/en/members/regulations-standards-and-guidance/.

This report is made solely to the Board of Directors of Health In Menopause Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Health In Menopause Limited and state those matters that we have agreed to state to the Board of Directors of Health In Menopause Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Health In Menopause Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Health In Menopause Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and loss of Health In Menopause Limited. You consider that Health In Menopause Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Health In Menopause Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

Page Kirk LLP
Chartered accountants and chartered tax advisers
Sherwood House
7 Gregory Boulevard
Nottingham
NG7 6LB

18 March 2025

 

Health In Menopause Limited

(Registration number: 12167424)
Abridged Balance Sheet as at 31 August 2024

Note

2024

2023
£

   

£

£

   

Fixed assets

   

 

Intangible assets

4

 

4,725

 

-

Tangible assets

5

 

38,759

 

26,480

   

43,484

 

26,480

Current assets

   

 

Debtors

13,330

 

23,335

 

Cash at bank and in hand

 

49,071

 

35,267

 

 

62,401

 

58,602

 

Creditors: Amounts falling due within one year

(73,099)

 

(6,067)

 

Net current (liabilities)/assets

   

(10,698)

 

52,535

Total assets less current liabilities

   

32,786

 

79,015

Provisions for liabilities

 

-

 

(3,615)

Accruals and deferred income

   

(1,936)

 

-

Net assets

   

30,850

 

75,400

Capital and reserves

   

 

Called up share capital

100

 

100

 

Profit and loss account

30,750

 

75,300

 

Shareholders' funds

   

30,850

 

75,400

 

Health In Menopause Limited

(Registration number: 12167424)
Abridged Balance Sheet as at 31 August 2024

For the financial year ending 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the director on 18 March 2025
 

.........................................
Dr A M Duffy
Director

 

Health In Menopause Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Sherwood House
7 Gregory Boulevard
Nottingham
NG7 6LB

These financial statements were authorised for issue by the director on 18 March 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Basis of preparation of financial statements

These financial statements were prepared under the historical cost convention in accordance with applicable United Kingdom accounting standards, including the Financial Reporting Standard 102 ('FRS 102') Section 1A small entities, and with the Companies Act 2006.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Government grants

Government grants are accounted for using the accrual model.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Health In Menopause Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2024

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Leasehold improvements

10% straight line

Office equipment

33.33% straight line

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Website

25% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Health In Menopause Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2024

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

During the year, the average number of employees at the company was 4 (2023 - 2).

 

Health In Menopause Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2024

4

Intangible assets

Website
 £

Total
£

Cost or valuation

Additions

5,400

5,400

At 31 August 2024

5,400

5,400

Amortisation

Amortisation charge

675

675

At 31 August 2024

675

675

Carrying amount

At 31 August 2024

4,725

4,725

5

Tangible assets

Leasehold improvements
£

Office equipment
 £

Total
£

Cost or valuation

At 1 September 2023

11,884

25,598

37,482

Additions

9,264

13,944

23,208

At 31 August 2024

21,148

39,542

60,690

Depreciation

At 1 September 2023

593

10,409

11,002

Charge for the year

1,912

9,017

10,929

At 31 August 2024

2,505

19,426

21,931

Carrying amount

At 31 August 2024

18,643

20,116

38,759

At 31 August 2023

11,291

15,189

26,480